World Imaging Breast & Prostate Cancer Technology Market Research Report 2021-2026: Existing, New and Evolving Imaging Approaches for Detecting and Treating Breast & Prostate Cancers

News provided by

Jan 07, 2022, 09:00 ET

DUBLIN, Jan. 7, 2022 /PRNewswire/ -- The "Imaging Breast & Prostate Cancer - Technologies, Market Trends and Applications, 2021" report has been added to ResearchAndMarkets.com's offering.

Breast & Prostate cancers have always been in the news due to their widespread occurrence, nature, complexity and aggressiveness. They are the two most commonly found invasive cancers in women and men, respectively.

In the last couple of decades, the detection, localization and diagnosis of these cancers has seen tremendous advances thanks to technology and innovation in the field of Medical imaging, recently focusing on noninvasive optical techniques. Imaging is an important part of cancer clinical protocols and can provide a variety of information about morphology, structure, metabolism and bodily functions.

Biomedical imaging can thus be used in the prediction, staging, screening, prognosis, biopsy guidance for diagnosis, plan of treatment, therapy guidance, therapy response recurrence and palliation of these cancers. With increasing cancer risk globally, there is a higher need for screening and diagnosis as early as possible.

Key Features of the Report

Existing, New and Evolving Imaging approaches for detecting and treating Breast & Prostate Cancers
Market revenue breakdown for the main Imaging modalities
Market forecast of Imaging modalities from 2020-2026
Presentation of dominant market trends
Summary of ongoing clinical trials, funded projects, investments and M&A's for cancer imaging.
Review of most promising upcoming systems/devices

Study Goals and Objectives

To provide a thorough analysis of the in vivo imaging modalities for breast and prostate cancer.
To summarize the global overview, prevalence, disease progression, trends, regulations and existing facilities for imaging breast and prostate cancer.
To detail and describe all the imaging technologies and its market segmentation.
To provide the product range, value chain, existing and upcoming market trends and forecast for imaging these cancers.
To analyse the technologies and strategies of the various actors and influencers in the value chain.

Key Topics Covered:

1. INTRODUCTION

Study Goals and Objectives
Information sources and methodology
Scope of the report
Glossary
Definitions
List of companies mentioned in the report

2. BREAST & PROSTATE CANCER FACTS

Prevalence
Scanning & Surgeries

3. TECHNOLOGY SEGMENTATION

Existing Technologies
Imaging Techniques for Breast & Prostate Cancer
Breast Imaging
Prostate Imaging
Medical Expectations

4. MARKET DATA AND TRENDS

Market Segmentation
Overview of Key Imaging Systems' manufacturers
Market and Forecast
Finance & Takeovers

5. NOTICEABLE UPCOMING R & D TECHNOLOGIES

Major centres/organisations for clinical trials
Funding/Projects
Patents' Landscape
Major Trends

6. REGULATORY ASPECTS

7. CONCLUSIONS

Companies Mentioned

AB-CT
Adani
AGFA Healthcare
Bio Medical International
Canon
CMR Naviscan,
DMS Imaging
Ecoray
Esaote
EXO
GE Healthcare
Genoray
Hologic
IMS Giotto,
Italray
Konica Minolta
Koning
Landwind Medical
Leica Biosystems
Lorad,
Metaltronica S.P.A.
Mindray
MS Westfalia
Panacea Engineering Medicine,
OncoVision
Philips
Planmed
Seno Medical
Siemens Healthineers
SIUI
Shimadzu,
Sternmed
Toshiba
Villa Sistemi Medicali S.P.A.

For more information about this report visit https://www.researchandmarkets.com/r/ijnhfc

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets